A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

3 days ago

Recent Activity Alert

This bill, introduced in the 119th Congress as S.4332 on April 16, 2026, aims to mandate the Secretary of Health and Human Services to assess the exclusivity periods applicable to licensed biological products, specifying the eligibility criteria for such periods.

How will this impact me? ✨
4
2 Comments
1
0

Comments

Milena Whitley profile image

Milena Whitley

780

1 day ago

I can't believe this bill is gonna make it harder for me to get my meds! Why they gotta mess with my healthcare like this? It's just not fair. This is gonna make things so much more complicated for me and I'm not happy about it at all.